We are live on ! Find out more
HI

HBK Investments Portfolio holdings

AUM $9.85B
1-Year Est. Return 55.6%
This Fund
S&P 500
This Quarter Est. Return
+31.23%
1 Year Est. Return
+55.6%
3 Year Est. Return
+156.38%
5 Year Est. Return
+423.64%
10 Year Est. Return
+2,347.17%
AUM
$2.37B
AUM Growth
-$11.7B
Cap. Flow
-$11.4B
Cap. Flow %
-481.89%
Top 10 Hldgs %
86.27%
Holding
391
New
7
Increased
7
Reduced
1
Closed
376

Sector Composition

Rank Sector Weight
1 Healthcare 31.81%
2 Technology 16.93%
3 Real Estate 15.53%
4 Energy 9.66%
5 Utilities 6.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTAA
301
DELISTED
FTAC Athena Acquisition Corp. Class A Ordinary Share
FTAA
-200,000
Closed -$1.99M
LGAC
302
DELISTED
Lazard Growth Acquisition Corp. I Ordinary Shares
LGAC
-500,000
Closed -$4.96M
ACDI
303
DELISTED
Ascendant Digital Acquisition Corp. III
ACDI
-502,560
Closed -$5.1M
ITQ
304
DELISTED
Itiquira Acquisition Corp. Class A Ordinary Shares
ITQ
-348,874
Closed -$3.46M
CTAQ
305
DELISTED
Carney Technology Acquisition Corp. II Class A Common Stock
CTAQ
-754,550
Closed -$7.51M
SCOB
306
DELISTED
ScION Tech Growth II Class A Ordinary Shares
SCOB
-406,942
Closed -$4.04M
GSQD
307
DELISTED
G Squared Ascend I Inc.
GSQD
-350,004
Closed -$3.47M
CPAR
308
DELISTED
Catalyst Partners Acquisition Corp. Class A Ordinary Share
CPAR
-402,100
Closed -$3.96M
DNZ
309
DELISTED
D and Z Media Acquisition Corp.
DNZ
-602,100
Closed -$5.94M
SVFA
310
DELISTED
SVF Investment Corp. Class A Ordinary Shares
SVFA
-250,689
Closed -$2.5M
NAAC
311
DELISTED
North Atlantic Acquisition Corporation Class A Ordinary Share
NAAC
-352,338
Closed -$3.5M
JCIC
312
DELISTED
Jack Creek Investment Corp. Class A Ordinary Shares
JCIC
-300,000
Closed -$2.98M
TZPS
313
DELISTED
TZP Strategies Acquisition Corp. Class A Ordinary Share
TZPS
-404,191
Closed -$4.02M
AEAC
314
DELISTED
Authentic Equity Acquisition Corp. Class A ordinary share
AEAC
-35,737
Closed -$356K
DLCA
315
DELISTED
Deep Lake Capital Acquisition Corp. Class A Ordinary Shares
DLCA
-404,700
Closed -$4.03M
FCAX
316
DELISTED
Fortress Capital Acquisition Corp.
FCAX
-749,900
Closed -$7.46M
FINM
317
DELISTED
Marlin Technology Corporation Class A Ordinary Share
FINM
-454,653
Closed -$4.52M
PACX
318
DELISTED
Pioneer Merger Corp. Class A Ordinary Share
PACX
-403,474
Closed -$4.02M
POW
319
DELISTED
Powered Brands Class A Ordinary Shares
POW
-473,748
Closed -$4.73M
EPHY
320
DELISTED
Epiphany Technology Acquisition Corp. Class A Common Stock
EPHY
-1,208,923
Closed -$11.9M
KAIR
321
DELISTED
Kairos Acquisition Corp. Class A Ordinary Shares
KAIR
-600,912
Closed -$5.98M
GIIX
322
DELISTED
Gores Holdings VIII, Inc. Class A Common Stock
GIIX
-600,000
Closed -$5.92M
FACA
323
DELISTED
Figure Acquisition Corp. I
FACA
-370,000
Closed -$3.65M
AKIC
324
DELISTED
Sports Ventures Acquisition Corp. Class A Ordinary Shares
AKIC
-610,677
Closed -$6.08M
FTVI
325
DELISTED
FinTech Acquisition Corp. VI Class A Common Stock
FTVI
-300,000
Closed -$2.98M

Similar funds

HBK Investments's Q4 2022 Portfolio in Review

As of Q4 2022, HBK Investments held 391 positions worth $2.37B, down 83% from $14.1B the previous quarter. Its ten largest holdings account for 86% of the portfolio.

HBK Investments withdrew a net $11.4B in Q4 2022, closing 376 positions and reducing 1 holding. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $537M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 4.1% a quarter earlier, followed by Technology and Real Estate.

Against the trend, HBK Investments opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $521M.

  • HBK Investments's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 4,576,000 shares worth $521M.
  • HBK Investments added most to STORE Capital Corporation in Q4 2022, an estimated $315M increase.
  • HBK Investments's biggest Q4 2022 reduction was Activision Blizzard, cutting an estimated $33.4M.
  • HBK Investments fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $537M.
  • HBK Investments's ten largest holdings make up 86% of its $2.37B portfolio in Q4 2022.
  • HBK Investments opened 7 new positions and closed 376 in Q4 2022.
  • HBK Investments's portfolio value fell 83% quarter-over-quarter to $2.37B.

Based on HBK Investments's 13F filing for Q4 2022, filed 14 Feb 2023.